Pony Testing International Group Co (300887) - Total Liabilities
Based on the latest financial reports, Pony Testing International Group Co (300887) has total liabilities worth CN¥593.17 Million CNY (≈ $86.80 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Pony Testing International Group Co cash conversion from operations to assess how effectively this company generates cash.
Pony Testing International Group Co - Total Liabilities Trend (2016–2024)
This chart illustrates how Pony Testing International Group Co's total liabilities have evolved over time, based on quarterly financial data. Check financial resilience of Pony Testing International Group Co to evaluate the company's liquid asset resilience ratio.
Pony Testing International Group Co Competitors by Total Liabilities
The table below lists competitors of Pony Testing International Group Co ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
SK Networks Co Ltd
KO:001740
|
Korea | ₩3.22 Trillion |
|
Metals X Limited
F:FG5
|
Germany | €85.98 Million |
|
Rashtriya Chemicals and Fertilizers Limited
NSE:RCF
|
India | Rs83.80 Billion |
|
Mavi Giyim Sanayi Ve Ticaret AS
IS:MAVI
|
Turkey | TL11.01 Billion |
|
Diversified United Investment Ltd
AU:DUI
|
Australia | AU$292.18 Million |
|
Zhejiang Dafeng Industrial Co Ltd
SHG:603081
|
China | CN¥4.84 Billion |
|
Sawit Sumbermas Sarana Tbk
JK:SSMS
|
Indonesia | Rp10.64 Trillion |
|
Hangzhou Minsheng Healthcare Co Ltd
SHE:301507
|
China | CN¥289.53 Million |
Liability Composition Analysis (2016–2024)
This chart breaks down Pony Testing International Group Co's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 300887 market cap overview.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.27 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.21 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.17 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Pony Testing International Group Co's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Pony Testing International Group Co (2016–2024)
The table below shows the annual total liabilities of Pony Testing International Group Co from 2016 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥762.19 Million ≈ $111.53 Million |
-12.46% |
| 2023-12-31 | CN¥870.63 Million ≈ $127.40 Million |
-15.37% |
| 2022-12-31 | CN¥1.03 Billion ≈ $150.53 Million |
+35.23% |
| 2021-12-31 | CN¥760.68 Million ≈ $111.31 Million |
+160.01% |
| 2020-12-31 | CN¥292.56 Million ≈ $42.81 Million |
-30.68% |
| 2019-12-31 | CN¥422.05 Million ≈ $61.76 Million |
+24.33% |
| 2018-12-31 | CN¥339.45 Million ≈ $49.67 Million |
+14.28% |
| 2017-12-31 | CN¥297.03 Million ≈ $43.47 Million |
+43.60% |
| 2016-12-31 | CN¥206.85 Million ≈ $30.27 Million |
-- |
About Pony Testing International Group Co
Pony Testing Co., Ltd. provides testing, measurement, calibration, inspection, evaluation, factory inspection, and other professional one-stop technical solutions in China. The company offers biopharmaceutical CRO/CDMO and drug testing services; medical device testing; medical testing/pathological diagnosis; toxicology and pathology experiments; food/liquor/beverage testing; agricultural product … Read more